A patient with type 1 diabetes received genetically modified allogeneic islets and no immunosuppression. Results obtained ...

A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression." ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...

Drug-resistant infections are already killing patients, lengthening hospital stays, raising treatment costs and weakening the ...

Multiple sclerosis is especially destructive because of its tendency to worsen progressively. Instead of working through the immune system, Quantum BioPharma’s Lucid-MS acts directly on the myelin ...

If you live with asthma, you may have wondered whether certain foods could be making your symptoms worse. While diet does not ...

Some of the smallest residents in an infant’s gut may be doing far more than anyone realized. Two linked studies published in ...

Summary: Researchers compiled emerging evidence to prove that astrocytes, traditionally dismissed as passive, structural ...

Rather than targeting the immune system, Quantum BioPharma’s Lucid-MS targets the myelin sheath. The case for Lucid-MS is grounded in more than a decade of rigorous science. Quantum BioPharma's path ...

Psoriasis is a chronic autoimmune condition that causes the skin to build up into scaly, inflamed patches—and if you live ...

IIT Kanpur researchers solve mystery of atypical drug target receptor ...